GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Functional Technologies Corp (TSXV:FEB.H) » Definitions » Change In Payables And Accrued Expense

Functional Technologies (TSXV:FEB.H) Change In Payables And Accrued Expense : C$0.15 Mil (TTM As of Aug. 2012)


View and export this data going back to . Start your Free Trial

What is Functional Technologies Change In Payables And Accrued Expense?

Functional Technologies's Change In Payables And Accrued Expense for the quarter that ended in Aug. 2012 was C$0.15 Mil. It means Functional Technologies's Accounts Payable & Accrued Expense increased by C$0.15 Mil from Aug. 2011 to Aug. 2012 .

Functional Technologies's Change In Payables And Accrued Expense for the fiscal year that ended in Aug. 2012 was C$0.15 Mil. It means Functional Technologies's Accounts Payable & Accrued Expense increased by C$0.15 Mil from Aug. 2011 to Aug. 2012 .


Functional Technologies Change In Payables And Accrued Expense Historical Data

The historical data trend for Functional Technologies's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Functional Technologies Change In Payables And Accrued Expense Chart

Functional Technologies Annual Data
Trend Aug03 Aug04 Aug05 Aug06 Aug07 Aug08 Aug09 Aug10 Aug11 Aug12
Change In Payables And Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 - 0.22 0.03 0.15

Functional Technologies Semi-Annual Data
Aug01 Aug02 Aug03 Aug04 Aug05 Aug06 Aug07 Aug08 Aug09 Aug10 Aug11 Aug12
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 - 0.22 0.03 0.15

Functional Technologies Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Aug. 2012 was C$0.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Functional Technologies Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Functional Technologies's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Functional Technologies (TSXV:FEB.H) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Functional Technologies Corp is incorporated under the corporate laws of British Columbia, Canada on October 18, 1999. The Company is a functional foods and biological health products company that is developing and commercializing advanced yeast products and other novel biological products for the food and health care industry. The company develops and commercializes proprietary, advanced yeast-based solutions to significant challenges in the food, beverage and healthcare industries, for which viable solutions are lacking. The Company's platform technologies improve the performance of innate yeast functions to primarily prevent the formation of naturally occurring toxins and contaminants that either affect final product quality or are classified by various global agencies as dangerous substances (e.g. carcinogens, neurotoxicants or reproductive toxicants). The Company operates in three geographic regions: Canada, Europe and the United States.

Functional Technologies (TSXV:FEB.H) Headlines

No Headlines